$775 Million is the total value of Soleus Capital Management, L.P.'s 65 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 54.4% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
XBI | New | SPDR SER TRcall | $126,560,000 | – | 1,408,100 | +100.0% | 16.33% | – |
UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $54,873,000 | +54.6% | 305,850 | +86.2% | 7.08% | +99.2% |
EPIX | Buy | ESSA PHARMA INC | $26,103,000 | -47.9% | 4,223,799 | +19.8% | 3.37% | -32.8% |
SRDX | Buy | SURMODICS INC | $25,314,000 | -1.3% | 558,440 | +4.8% | 3.27% | +27.2% |
EDAP | EDAP TMS S Asponsored adr | $22,827,000 | +21.0% | 3,148,609 | 0.0% | 2.94% | +56.0% | |
ANGO | Buy | ANGIODYNAMICS INC | $22,110,000 | +55.5% | 1,026,450 | +99.1% | 2.85% | +100.4% |
ILMN | New | ILLUMINA INC | $21,768,000 | – | 62,300 | +100.0% | 2.81% | – |
OSUR | New | ORASURE TECHNOLOGIES INC | $20,714,000 | – | 3,055,193 | +100.0% | 2.67% | – |
ORGO | Buy | ORGANOGENESIS HLDGS INC | $19,356,000 | +4.8% | 2,540,167 | +27.1% | 2.50% | +35.0% |
IRMD | Sell | IRADIMED CORP | $19,283,000 | -7.3% | 430,051 | -4.4% | 2.49% | +19.5% |
KRYS | Buy | KRYSTAL BIOTECH INC | $19,252,000 | +20.5% | 289,337 | +26.7% | 2.48% | +55.2% |
NPCE | Buy | NEUROPACE INC | $19,080,000 | -18.0% | 2,324,003 | +0.6% | 2.46% | +5.7% |
THTX | THERATECHNOLOGIES INC | $18,846,000 | -19.1% | 7,692,082 | 0.0% | 2.43% | +4.2% | |
Buy | DICE THERAPEUTICS INC | $18,824,000 | -8.3% | 983,994 | +21.3% | 2.43% | +18.2% | |
APEN | Buy | APOLLO ENDOSURGERY INC | $17,503,000 | -9.5% | 2,893,100 | +26.1% | 2.26% | +16.6% |
HOLX | New | HOLOGIC INC | $17,331,000 | – | 225,600 | +100.0% | 2.24% | – |
ISEE | Sell | IVERIC BIO INC | $16,232,000 | -9.1% | 964,476 | -9.7% | 2.09% | +17.1% |
EOLS | Buy | EVOLUS INC | $15,353,000 | +87.3% | 1,368,389 | +8.7% | 1.98% | +141.6% |
ENTA | Sell | ENANTA PHARMACEUTICALS INC | $14,413,000 | -39.4% | 202,485 | -36.4% | 1.86% | -22.0% |
NRIX | Buy | NURIX THERAPEUTICS INC | $14,173,000 | -34.1% | 1,011,638 | +36.1% | 1.83% | -15.1% |
New | ARCELLX INC | $13,876,000 | – | 989,739 | +100.0% | 1.79% | – | |
FGEN | Sell | FIBROGEN INC | $12,794,000 | -41.5% | 1,064,356 | -31.4% | 1.65% | -24.6% |
BCAB | BIOATLA INC | $12,577,000 | -74.5% | 2,515,424 | 0.0% | 1.62% | -67.2% | |
PIRS | Buy | PIERIS PHARMACEUTICALS INC | $12,529,000 | +382.3% | 4,134,868 | +501.5% | 1.62% | +521.5% |
INSP | Buy | INSPIRE MED SYS INC | $12,295,000 | +94.7% | 47,900 | +74.5% | 1.59% | +150.9% |
SNN | Sell | SMITH & NEPHEW PLCspdn adr new | $12,282,000 | -40.2% | 385,000 | -35.1% | 1.58% | -22.9% |
STE | Sell | STERIS PLC | $9,975,000 | -21.3% | 41,260 | -20.8% | 1.29% | +1.3% |
LNTH | Sell | LANTHEUS HLDGS INC | $9,869,000 | -80.6% | 178,427 | -89.9% | 1.27% | -75.1% |
CVS | Sell | CVS HEALTH CORP | $9,362,000 | -34.2% | 92,500 | -33.0% | 1.21% | -15.2% |
SUPN | New | SUPERNUS PHARMACEUTICALS INC | $8,112,000 | – | 251,000 | +100.0% | 1.05% | – |
TXG | New | 10X GENOMICS INC | $8,074,000 | – | 106,139 | +100.0% | 1.04% | – |
FATE | Buy | FATE THERAPEUTICS INC | $7,983,000 | +1650.7% | 205,900 | +2539.7% | 1.03% | +2139.1% |
PCVX | Buy | VAXCYTE INC | $7,930,000 | +13.1% | 328,350 | +11.4% | 1.02% | +45.7% |
MIRM | New | MIRUM PHARMACEUTICALS INC | $7,564,000 | – | 343,500 | +100.0% | 0.98% | – |
AZN | Sell | ASTRAZENECA PLCsponsored adr | $7,476,000 | -73.2% | 112,696 | -76.5% | 0.96% | -65.5% |
EIGR | New | EIGER BIOPHARMACEUTICALS INC | $6,499,000 | – | 783,000 | +100.0% | 0.84% | – |
NTRA | Sell | NATERA INC | $6,305,000 | -70.3% | 155,000 | -31.9% | 0.81% | -61.8% |
DXCM | Buy | DEXCOM INC | $5,939,000 | +42.6% | 11,609 | +49.6% | 0.77% | +83.7% |
XENE | Sell | XENON PHARMACEUTICALS INC | $5,802,000 | -51.0% | 189,797 | -49.9% | 0.75% | -36.8% |
CVRX | CVRX INC | $5,763,000 | -51.0% | 962,165 | 0.0% | 0.74% | -36.9% | |
NEO | New | NEOGENOMICS INC | $5,589,000 | – | 460,000 | +100.0% | 0.72% | – |
INMD | New | INMODE LTD | $5,407,000 | – | 146,500 | +100.0% | 0.70% | – |
CCCC | Sell | C4 THERAPEUTICS INC | $4,045,000 | -77.6% | 166,736 | -70.3% | 0.52% | -71.1% |
SKIN | New | THE BEAUTY HEALTH COMPANY | $3,842,000 | – | 227,612 | +100.0% | 0.50% | – |
SIEN | Sell | SIENTRA INC | $3,644,000 | -47.5% | 1,641,337 | -13.2% | 0.47% | -32.4% |
IO BIOTECH INC | $3,565,000 | -17.2% | 672,734 | 0.0% | 0.46% | +6.7% | ||
XILIO THERAPEUTICS INC | $3,376,000 | -55.8% | 477,495 | 0.0% | 0.44% | -43.0% | ||
ARYD | ARYA SCIENCES ACQU CORP IVcl a | $2,940,000 | -1.2% | 300,000 | 0.0% | 0.38% | +27.2% | |
YMAB | Sell | Y-MABS THERAPEUTICS INC | $2,839,000 | -43.6% | 238,982 | -23.0% | 0.37% | -27.4% |
IMUX | Buy | IMMUNIC INC | $2,712,000 | +61.9% | 240,000 | +37.1% | 0.35% | +108.3% |
ISRG | New | INTUITIVE SURGICAL INC | $2,353,000 | – | 7,800 | +100.0% | 0.30% | – |
CLDX | New | CELLDEX THERAPEUTICS INC NEW | $2,350,000 | – | 69,000 | +100.0% | 0.30% | – |
VSTM | VERASTEM INC | $2,319,000 | -31.2% | 1,644,500 | 0.0% | 0.30% | -11.3% | |
LQDA | Buy | LIQUIDIA CORPORATION | $2,107,000 | +87.0% | 293,485 | +26.8% | 0.27% | +140.7% |
New | CYTEK BIOSCIENCES INC | $1,940,000 | – | 180,000 | +100.0% | 0.25% | – | |
CARA | Sell | CARA THERAPEUTICS INC | $1,934,000 | -62.8% | 159,200 | -62.7% | 0.25% | -52.0% |
PCRX | Sell | PACIRA BIOSCIENCES INC | $1,698,000 | -72.2% | 22,250 | -78.1% | 0.22% | -64.2% |
PLRX | New | PLIANT THERAPEUTICS INC | $1,682,000 | – | 240,000 | +100.0% | 0.22% | – |
VRDN | VIRIDIAN THERAPEUTICS INC | $1,664,000 | -6.5% | 90,000 | 0.0% | 0.22% | +20.8% | |
NVCR | Sell | NOVOCURE LTD | $1,431,000 | -14.4% | 17,275 | -22.4% | 0.18% | +10.8% |
CRSP | CRISPR THERAPEUTICS AGnamen akt | $1,381,000 | -17.2% | 22,000 | 0.0% | 0.18% | +6.6% | |
BRIDGEBIO PHARMA INCnote 2.500% 3/1 | $1,170,000 | -18.9% | 1,950,000 | 0.0% | 0.15% | +4.9% | ||
Sell | DA32 LIFE SCNCE TEC ACQSTN C | $972,000 | -71.7% | 100,000 | -71.4% | 0.12% | -63.7% | |
OLK | New | OLINK HLDG ABsponsored ads | $953,000 | – | 53,961 | +100.0% | 0.12% | – |
CELC | CELCUITY INC | $300,000 | -29.1% | 32,073 | 0.0% | 0.04% | -7.1% | |
LYRA | Exit | LYRA THERAPEUTICS INC | $0 | – | -10,000 | -100.0% | -0.00% | – |
NGM | Exit | NGM BIOPHARMACEUTICALS INC | $0 | – | -13,000 | -100.0% | -0.02% | – |
BEAM | Exit | BEAM THERAPEUTICS INC | $0 | – | -2,850 | -100.0% | -0.02% | – |
BCYC | Exit | BICYCLE THERAPEUTICS PLCsponsored ads | $0 | – | -10,250 | -100.0% | -0.06% | – |
HOWL | Exit | WEREWOLF THERAPEUTICS INC | $0 | – | -64,585 | -100.0% | -0.08% | – |
ARVN | Exit | ARVINAS INC | $0 | – | -11,000 | -100.0% | -0.09% | – |
Exit | AVALO THERAPEUTICS INC | $0 | – | -770,000 | -100.0% | -0.13% | – | |
VNDA | Exit | VANDA PHARMACEUTICALS INC | $0 | – | -158,700 | -100.0% | -0.25% | – |
CCXI | Exit | CHEMOCENTRYX INC | $0 | – | -68,320 | -100.0% | -0.25% | – |
ZGNX | Exit | ZOGENIX INC | $0 | – | -175,152 | -100.0% | -0.28% | – |
CUTR | Exit | CUTERA INC | $0 | – | -86,180 | -100.0% | -0.36% | – |
ARNA | Exit | ARENA PHARMACEUTICALS INC | $0 | – | -40,000 | -100.0% | -0.37% | – |
ABBV | Exit | ABBVIE INC | $0 | – | -27,500 | -100.0% | -0.37% | – |
DYN | Exit | DYNE THERAPEUTICS INC | $0 | – | -338,760 | -100.0% | -0.40% | – |
BAX | Exit | BAXTER INTL INC | $0 | – | -51,000 | -100.0% | -0.44% | – |
KDNY | Exit | CHINOOK THERAPEUTICS INC | $0 | – | -298,700 | -100.0% | -0.49% | – |
GLPG | Exit | GALAPAGOS NVspon adr | $0 | – | -98,800 | -100.0% | -0.54% | – |
BVS | Exit | BIOVENTUS INC | $0 | – | -428,397 | -100.0% | -0.62% | – |
IWM | Exit | ISHARES TRput | $0 | – | -508,500 | -100.0% | -11.32% | – |
XBI | Exit | SPDR SER TRput | $0 | – | -1,292,000 | -100.0% | -14.48% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ESSA PHARMA INC | 16 | Q3 2023 | 10.8% |
IRADIMED CORP | 16 | Q3 2023 | 5.8% |
XENON PHARMACEUTICALS INC | 15 | Q3 2023 | 2.9% |
IVERIC BIO INC | 14 | Q1 2023 | 6.5% |
SURMODICS INC | 14 | Q3 2023 | 4.7% |
NATERA INC | 13 | Q3 2023 | 3.9% |
DEXCOM INC | 13 | Q2 2023 | 4.2% |
NOVOCURE LTD | 13 | Q3 2023 | 3.4% |
CRISPR THERAPEUTICS AG | 13 | Q2 2023 | 2.6% |
LYRA THERAPEUTICS INC | 13 | Q3 2023 | 1.0% |
View Soleus Capital Management, L.P.'s complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
13F-HR | 2021-11-15 |
View Soleus Capital Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.